Roilides E, Walsh T J, Rubin M, Venzon D, Pizzo P A
Infectious Diseases Section, Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland 20892.
Antimicrob Agents Chemother. 1990 Feb;34(2):196-201. doi: 10.1128/AAC.34.2.196.
Polymorphonuclear leukocytes (PMNs) are an important component of the host defense against fungi. We investigated the influence of five antifungal agents on PMN function and compared them with amphotericin B (AmB). The in vitro effects of AmB, flucytosine, ketoconazole, fluconazole, Sch-39304, and cilofungin (LY121019) on chemotaxis, phagocytosis, oxidative metabolism of PMN as reflected by superoxide anion (O2-) generation, and intracellular killing of Candida albicans blastoconidia were examined. With regard to chemotaxis in response to N-formylmethionyl-leucyl-phenylalanine, as measured by the multiwell chamber method, AmB induced a marked decrease (greater than or equal to 5 micrograms/ml), whereas ketoconazole at 5 micrograms/ml enhance it. Phagocytosis was significantly decreased after pretreatment of PMNs with AmB and Sch-39304 (greater than 5 and 1 to 10 micrograms/ml, respectively). O2- production after stimulation of PMNs with N-formylmethionyl-leucyl-phenyl-alanine was significantly decreased by AmB (greater than 5 micrograms/ml) and enhanced by Sch-39304 (1 to 5 micrograms/ml). In contrast, intracellular killing, as tested by methylene blue staining, was enhanced by ketoconazole (5 micrograms/ml) and Sch-39304 (1 to 5 micrograms/ml). Flucytosine, fluconazole, and cilofungin did not affect PMN function at therapeutic concentrations. The results of this comprehensive study indicate that AmB, flucytosine, cilofungin, and the newer azoles, at safely achievable concentrations, generally do not suppress PMN function at therapeutic enhance selective functions.
多形核白细胞(PMNs)是宿主抵御真菌的重要组成部分。我们研究了五种抗真菌药物对PMN功能的影响,并将它们与两性霉素B(AmB)进行比较。检测了AmB、氟胞嘧啶、酮康唑、氟康唑、Sch-39304和西洛芬净(LY121019)对PMN趋化性、吞噬作用、超氧阴离子(O2-)生成所反映的氧化代谢以及白色念珠菌芽生孢子的细胞内杀伤作用的体外影响。关于通过多孔板法测量的对N-甲酰甲硫氨酰-亮氨酰-苯丙氨酸的趋化性,AmB诱导显著降低(大于或等于5微克/毫升),而5微克/毫升的酮康唑则增强趋化性。用AmB和Sch-39304(分别大于5微克/毫升和1至10微克/毫升)预处理PMN后,吞噬作用显著降低。用N-甲酰甲硫氨酰-亮氨酰-苯丙氨酸刺激PMN后,AmB(大于5微克/毫升)显著降低O2-生成,而Sch-39304(1至5微克/毫升)则增强O2-生成。相比之下,通过亚甲蓝染色测试的细胞内杀伤作用,酮康唑(5微克/毫升)和Sch-39304(1至5微克/毫升)可增强。氟胞嘧啶、氟康唑和西洛芬净在治疗浓度下不影响PMN功能。这项综合研究的结果表明,AmB、氟胞嘧啶、西洛芬净和新型唑类药物在安全可达到的浓度下,在治疗时通常不会抑制PMN功能,反而会增强选择性功能。